# Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients

> **NCT04181190** · — · COMPLETED · sponsor: **Università degli Studi di Ferrara** · enrollment: 130 (actual)

## Conditions studied

- Asthma
- Asthma; Eosinophilic

## Interventions

- **DIAGNOSTIC_TEST:** Total IgE
- **DIAGNOSTIC_TEST:** Blood cell counts
- **DIAGNOSTIC_TEST:** Asthma control assessment
- **DIAGNOSTIC_TEST:** lung function tests

## Key facts

- **NCT ID:** NCT04181190
- **Lead sponsor:** Università degli Studi di Ferrara
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-11
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181190, "Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04181190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*